Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Sundaram, Jeyapriya Rajaa; b; 1 | Poore, Charlene Priscillaa; c | Sulaimee, Noor Hazim Bina; b | Pareek, Teje | Cheong, Wei Funa; c | Wenk, Markus R.a; c | Pant, Harish C.f | Frautschy, Sally A.g; h | Low, Chian-Minga; b; d | Kesavapany, Sashia; c; *
Affiliations: [a] Neurobiology and Ageing Program, Centre for Life Sciences, Yong Loo Lin School of Medicine, National University of Singapore, Singapore | [b] Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore | [c] Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore | [d] Department of Anaesthesia, Yong Loo Lin School of Medicine, National University of Singapore, Singapore | [e] Department of Pediatrics, Case Western Reserve University, Cleveland, OH, USA | [f] National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA | [g] Department of Neurology, University of California, Los Angeles, CA, USA | [h] Geriatric Research Education and Clinical Center, Veterans Greater Los Angeles Healthcare System, Los Angeles, CA, USA
Correspondence: [*] Correspondence to: Sashi Kesavapany, NTU Institute for Health Technologies, Nanyang Technological University, Research Techno Plaza, XFrontiers Block, #02-07, 50 Nanyang Drive, Singapore 637553. Tel.: +65 65923516; Fax: +65 67943735; E-mail: SashiKesavapany@ntu.edu.sg.
Note: [1] Current address: Duke-NUS Medical School Singapore,Singapore.
Abstract: Several studies have indicated that neuroinflammation is indeed associated with neurodegenerative disease pathology. However, failures of recent clinical trials of anti-inflammatory agents in neurodegenerative disorders have emphasized the need to better understand the complexity of the neuroinflammatory process in order to unravel its link with neurodegeneration. Deregulation of Cyclin-dependent kinase 5 (Cdk5) activity by production of its hyperactivator p25 is involved in the formation of tau and amyloid pathology reminiscent of Alzheimer’s disease (AD). Recent studies show an association between p25/Cdk5 hyperactivation and robust neuroinflammation. In addition, we recently reported the novel link between the p25/Cdk5 hyperactivation-induced inflammatory responses and neurodegenerative changes using a transgenic mouse that overexpresses p25 (p25Tg). In this study, we aimed to understand the effects of early intervention with a potent natural anti-inflammatory agent, curcumin, on p25-mediated neuroinflammation and the progression of neurodegeneration in p25Tg mice. The results from this study showed that curcumin effectively counteracted the p25-mediated glial activation and pro-inflammatory chemokines/cytokines production in p25Tg mice. Moreover, this curcumin-mediated suppression of neuroinflammation reduced the progression of p25-induced tau/amyloid pathology and in turn ameliorated the p25-induced cognitive impairments. It is widely acknowledged that to treat AD, one must target the early-stage of pathological changes to protect neurons from irreversible damage. In line with this, our results demonstrated that early intervention of inflammation could reduce the progression of AD-like pathological outcomes. Moreover, our data provide a rationale for the potential use of curcuminoids in the treatment of inflammation associated neurodegenerative diseases.
Keywords: Amyloid, Cdk5, curcumin, neurodegeneration, neuroinflammation, p25, tau
DOI: 10.3233/JAD-170093
Journal: Journal of Alzheimer's Disease, vol. 60, no. 4, pp. 1429-1442, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl